FLUDEOXYGLUCOSE (F-18)
We will be changing our web hosting provider during the next few days.
During this time, the site may work slowly or be unavailable.
We apologize for the inconvenience and kindly ask you to be patient!
Google image searchProduct monograph
Active ingredient
fludeoxyglucose 18f, 232 GBQ/VIAL
DIN: 02462354
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: >0.5 GBQ
Schedule: Schedule C
Company: LAWSON HEALTH RESEARCH INSTITUTE
Date: 17-OCT-2018
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09I — TUMOUR DETECTION (ATC, ATC/DDD)
- V09IX — Other diagnostic radiopharmaceuticals for tumour detection (ATC, ATC/DDD)
- V09IX04 — FLUDEOXYGLUCOSE (18F) (ATC/DDD)
